Surveillance Imaging in Individuals at High Risk for Pancreatic Cancer: Not a Ceiling, but Rather a Floor Upon Which to Build

by Rosenthal, M.H, Wolpin, B.M, Yurgelun, M.B
Published 2022

Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial

by Bekaii-Saab, T., Dakhil, S.R, Faggen, M., Fuchs, C.S, Heying, E.N, Lipsyc-Sharf, M., Meyerhardt, J.A, Ng, K., Noble, S., Ou, F.-S, Rubinson, D.A, Schrag, D., Schuetz, S.R, Stella, P.J, Weckstein, D.J, Wender, D.B, Yurgelun, M.B, Zemla, T.J
Published 2022